Abstract same manner. The high-dose model was highly fatal and used for estimation of the survival rate. The low-dose model was investigated to evaluate alterations in the number of tumors, histological findings, and cytokine expression in the liver and spleen. Nontumor-bearing rats were employed for study of any adverse effects gene gun shots induce on body weight, peripheral blood cell counts, and liver function.
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and interleukin (IL)-12, are known to have remarkable anti-tumoral effects (Gutterman 1994; Jenks 1996; Rosenberg, Lotze, et al., 1989; Watanabe, Yamauchi et al., 1994) . As therapeutic agents, however, these substances, if administered systemically, have often been associated with serious side effects (Blick, Sherwin et al., 1987; Gutterman 1994; Jenks 1996; Watanabe, Yamauchi, et al., 1994) . In light of this, local injection may seem favorable; however, cytokines are too short acting to remain in the tumor.
Gene transfection therapy, first developed as a breakthrough strategy for treating hereditary diseases (Blaese, Culver et al., 1995) , can confer semi-permanent efficacy and be expected to be useful in the treatment of malignant neoplasms. Despite its encouraging results with hematological disorders (Blaese, Culver et al., 1995) , the new biomedical technology still encounters difficulty when addressing solid cancers (Anderson, 1998; Marcel, Grausz 1997; Rosenberg, Aebersold et al., 1990) . A novel delivery system is required to efficiently and specifically transfer genes into targets without compromising the patient's safety.
A gene gun is a unique delivery modality with the advantage of immunity to viral vector-associated complications . Also, genes can be incorporated using this approach at any period of the proliferative cell cycle. Simultaneous inducement of multiple genes is also possible (Kagawa, 1995) .
In the preceding articles, we demonstrated the characteristics of a hand-held gene gun system and its beneficial effects on solid 1998). The present study investigated the effects of IL-12 gene gun therapy on experimental metastatic tumors of the rat liver to evaluate the clinical feasibility of intraoperative treatment of patients with hepatic metastases. AH130 cells (Endo, Shinoki et al., 1968) were kindly provided from Kyowa Hakko Co. Ltd. (Tokyo, Japan). The original cells were kept in liquid nitrogen. After a part of the cells were thawed, they were consecutively maintained within the hydroperitonea of three Donryu rats. In preliminary investigations, it was found that multiple consecutive subcultures tended to alter the virulence of the tumor cells.
Therefore, we used only the second or third generation sub-cultured tumor cells for the following experiments.
Gene gun
The Helios TM Gene Gun System (Bio-Rad Laboratories, CA, USA) was used according to the manual of the manufacturer (catalog numbers 165-2431 and 165-2432).
Details of the method have been described in our previous reports Kagawa, 1995; Kobayshi, Yoshida et al., 1997) .
Preparation of IL-12 cDNA-coated gold particles
The DNA plasmid of pCAGGS/mouse IL-12 (8.8kb, kindly provided by Genetics Institute, MA, USA) was attached to gold (Au) particles (Nippon Bio-Rad, Tukuba, CA, USA) was also attached to the Au particles in the same way and used as a control marker gene. The details of the Au particle coating procedure have been described previously Kagawa, 1995; coated Au particles were transferred to a 15ml tube and adjusted to a final volume of 6 ml using PVP solution [polyvinyl pyrrolidone (molecular weight 360,000) 0.02mg/ml vein after undergoing laparotomy under nembutal (i. p.) anesthesia. Three rats died within ten days after inoculation. In all three, autopsy revealed portal vein thrombosis as a cause of death. The other 27 tumor-bearing rats were randomly divided into two groups.
Twelve days after inoculation, both groups underwent gene gun bombardments onto the gal) cDNA. The gene gun bombardment in each rat consisted of four shots of DNAcoated Au particles emitted by pressurized helium gas at 300 psi (1 psi=6890Pa). The rats in both groups were observed up to 60 days following the inoculation.
Evaluation of tumor suppression in the lower-dose model after gene gun therapy and countable number of metastatic nodules in the liver without any death up to a period of 20 days. We, therefore, called this scheme a lower-dose model and used it for the quantitative and histological evaluation of tumor suppression by gene gun therapy.
undergoing laparotomy under nembutal anesthesia. At day 12 following the inoculation, the number of metastatic tumors on the hepatic surface were microscopically counted by two examiners. The animals were randomly divided into two groups (n=7, in each). The For measurement of normal serological values, another six normal rats not having undergone gene gun bombardments were used as a control.
Statistical analysis
Data were presented as mean ± standard deviation (SD). Statistical differences between the two groups were evaluated using the unpaired student's t-test. The differences in survival rates were analyzed by Kaplan-Meier's method and the log rank test. Calculations were performed using the software for Macintosh (Statview TM, Abacus Concepts, Berkely, CA, USA). Values of p<0.05 were considered significant.
Results
Survival rate following gene therapy in the high-dose model (Brunda, Luistro, Warner et al., 1993; Wigginton, Komschlies et al., 1996) . However, clinical trials of rIL-12 administered systemically have caused severe toxicity including death due to side effects (Atkins, Roertson, Gorden et al., 1996) . To avoid adverse systemic effects and to induce local response at the specific site of the cancer, gene therapy using DNAs of IL-12 which produces superior anti-tumor effects, should be investigated. In this respect, gene gun therapy appears to be promising (Kagawa, 1995; Kobayashi, Yoshida, et al., 1993) .
Other non-viral vectors or techniques for gene therapy may include lipofection and electroporation, but Thompson, Gould et al., 1998 reported that local cytokine expression by particle bombardment (gene gun) was at least fivefold more efficient than by lipofection or electroporation (Thompson, Gould, Bukholder et al., 1993) . have described the results of cytokine gene therapy using a gene gun in a murine model (Rakhmilevich, Janssen et al., 1997; Sun, Burkholder, Sun et and successfully inhibited tumor growth and produced a prolongation of survival.
According to a mouse experiment by (Rakhmilevich, Turner et al., 1996) when the IL-12 gene had been transferred with a gene gun into the tumor before surgery, metastases could be prevented after resection of the primary tumor (Rakhmilevich, Turner, et al., 1996) . These successful results were obtained only by repeated administration of cytokine genes, which means that this technical scheme may be impractical in a clinical setting, especially in consideration of the necessity of laparotomy for the treatment of intra-abdominal tumors. A hand-held gene gun appears especially useful because it may be able to attain therapeutic effects during a single laparotomy.
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Despite its advantages mentioned above, gene gun therapy seems to have the following two potential disadvantages. First, homogenous introduction of genes into the tumor is difficult to accomplish because the maximum delivery focuses on the surface nearest to the nozzle and marked attenuation occurs in the peripheral or deep portion of the tumor . This characteristic extremely lessens the efficacy of gene gun therapy using genes of p-53 (Roth, Nguyen et al., 1996) or ras (Aoki, Yoshida et al., 1995) , etc. whose homogenous incorporation into as many tumor cells as possible (ideally all cells) is desirable for satisfactory results. However, cytokine gene therapy (especially IL-12) seems to work by activating the cytokine network, providing the possibility of remarkable anti-tumor effects even with spotty gene introduction into some target cells .
The second conceivable problem with gene gun therapy may involve the mechanical damage and gas embolisms caused by highly pressurized helium gas. The hemato-serological changes caused by pressurized gas seem to be tolerable. Although in the present study the pressure of 300 psi provoked only slight bleeding in a few cases, our preliminary studies revealed that two shots at exactly the same point at 300 psi caused a rupture of the liver surface. If gene gun therapy is to be applied clinically in the future, the gas pressure used and the bombardment site should be evaluated in light of organ anatomy.
et al., 1994), and it had been reported that the gene expression introduced by a gene gun was highest at days one to three after therapy (Williams, Johnston et al., 1991) .
and spleen two days following gene therapy. Despite a slight increase in the total amount of cytokines in the IL-12 gene therapy group, the difference was not significant. Thus, mechanisms other than the immediate actions of the cytokines themselves may be involved in the favorable therapeutic effects of IL-12 gene gun therapy. Hashimoto, Takeda et al., (1995) examined the anti-tumoral effect of rIL-12 in a murine liver metastasis model and reported that NK T cells, not IL-12 itself, played an important role against neoplasm (Hashimoto, Takeda, et al., 1995 (Siders, Wright et al., 1998 ).
In conclusion, IL-12 gene therapy may be clinically applied as a promising therapeutic option for patients with multiple liver metastases whose prognosis remains poor. A hand-held gene gun seems especially useful for transfection during laparotomy, due to its ability to accurately and instantaneously inject exogenous genes under direct vision.
